Better Obesity Drug Race: Novo Nordisk vs Lilly 2026
In the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
Indexes reflect complex forces like market moves, composition, and weighting. This intro explains the main factors that move index performance.
15,399 articlesIn the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
Memory shortages are expanding beyond PCs to consoles and smart devices. Even Apple’s famed supply chain isn’t immune...
JPMorgan Chase moves to a two-person succession test by naming Doug Petno and Troy Rohrbaugh co-presidents, laying th...
A Live Oak Bancshares director sold 8,400 shares for about $336,000. Learn what this kind of insider action can signa...
Chip shares jumped as risk appetite returned to markets, with Intel and AMD leading a broader move higher on AI infra...
Sezzle continues to gain traction in a competitive BNPL market. This article examines why sezzle still looks attracti...
Lizex.io announces a global B2B partnership program, linking crypto wallets, rate aggregators, and fintech apps to it...
UiPath edges higher as investors monitor its agentic automation strategy ahead of earnings. This analysis breaks down...
June payrolls rose just 57,000, signaling softer momentum. Yet three AI-driven stocks offer durable upside as corpora...
SK Hynix plans a $29 billion U.S. listing to capitalize on AI memory chip demand, highlighting a push to broaden inve...
A DXP Enterprises director sold nearly 7,000 shares in a single transaction. This article breaks down the details, ex...
If you’re wondering whether Eli Lilly stock still has room to run, you’re not alone. This guide outlines scenarios fo...